|Articles|May 17, 2004
Hospitals start pilot testing RFID to curb drug diversion
M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Tradipitant for Prevention of Vomiting From Motion Sickness
2
Rethinking Acute Pain Management in the Age of Prescription Topicals
3
Pharmacists Must Effectively Balance Risks, Benefits of Social Media Use
4
Orforglipron Maintains Weight Loss After Discontinuation of Injectable GLP-1
5










































































































